The antiphospholipid syndrome (APS) is characterized by the presence of pathogenic autoantibodies against β2-glycoprotein-I (β2GPI) that can appear as a secondary complication to microbial infections, but the mechanisms involved remain unclear. In March 15
Blank et al. evaluated the APS-related pathogenic potential of microbial pathogens carrying sequences related to a hexapeptide (TLRVYK), recognized specifically by a pathogenic anti-β2GPI monoclonal antibody. They injected mice with extracts from a panel of microbial preparations and found high titers of antipeptide TLRVYK anti-β2GPI antibodies in mice immunized with Haemophilus influenzae, Neisseria gonorrhoeae, or tetanus toxoid. When naïve mice were infused with the affinity-purified antipeptide antibodies they showed substantial thrombocytopenia, prolonged activated partial tromboplastin time and elevated percentage of fetal loss, similar to ...